NOVUM APR

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: NOVUM APR
Generic name: MENTHOL
Manufacturer: NOVUM SOLUTIONS INC
Product type: HUMAN OTC DRUG
SPL set ID: 1b869a1f-5787-4d03-a546-43a8217b2b2c
SPL ID: 32322747-0600-c81a-e063-6394a90ac71e
Version: 7
Effective date: 2025-04-07
Source export date: 2026-09-28
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:54:04

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		NOVUM APR	openfda.brand_name
generic name		MENTHOL	openfda.generic_name
manufacturer name		NOVUM SOLUTIONS INC	openfda.manufacturer_name
ndc	package	69574-005-05	openfda.package_ndc
ndc	package	69574-005-04	openfda.package_ndc
ndc	product	69574-005	openfda.product_ndc
ndc11	package	69574000504	derived:openfda.package_ndc
ndc11	package	69574000505	derived:openfda.package_ndc
rxcui		1314935	openfda.rxcui
spl id		32322747-0600-c81a-e063-6394a90ac71e	id
spl set id		1b869a1f-5787-4d03-a546-43a8217b2b2c	set_id
unii		L7T10EIP3A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Not intended for use on children under 2 years old except as directed by a doctor. Avoid contact with eyes. For external use only. If irritation develops and persists, discontinue use and consult a doctor. If condition worsens or if symptoms persist more than 7 days or clear up and occur again within a few days, discontinue use and consult a doctor.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.